AN UNBIASED VIEW OF MBL77

mutations given the fact that, as stated down below, CLL therapy relies on the existence or absence of these mutations. The current consensus is the fact, aside from clonal mutations, subclonal mutations by using a variant allelic frequency ranging from five to ten% (and so below the brink of detection by common molecular tactics) is also noted, Wh